Testing for Differences in Survival When Treatment Effects Are Persistent, Decaying, or Delayed
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Testing for Differences in Survival When Treatment Effects Are Persistent, Decaying, or Delayed
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
American Society of Clinical Oncology (ASCO)
Online
2022-06-30
DOI
10.1200/jco.21.01811
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Robust Design and Analysis of Clinical Trials With Non-proportional Hazards: A Straw Man Guidance from a Cross-pharma Working Group
- (2021) Satrajit Roychoudhury et al. Statistics in Biopharmaceutical Research
- The Short-Term and Long-Term Hazard Ratio Model: Parameterization Inconsistency
- (2020) Philippe Flandre et al. AMERICAN STATISTICIAN
- Is the Log-Rank and Hazard Ratio Test/Estimation the Best Approach for Primary Analysis for All Trials?
- (2020) Hajime Uno et al. JOURNAL OF CLINICAL ONCOLOGY
- Estimating Treatment Effect as the Primary Analysis in a Comparative Study: Moving Beyond P Value
- (2020) Bo Huang et al. JOURNAL OF CLINICAL ONCOLOGY
- Dynamic RMST curves for survival analysis in clinical trials
- (2020) Jason J. Z. Liao et al. BMC Medical Research Methodology
- Combined test versus logrank/Cox test in 50 randomised trials
- (2019) Patrick Royston et al. Trials
- Comparing Kaplan–Meier curves with delayed treatment effects: applications in immunotherapy trials
- (2019) Philippe Flandre et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS
- Modestly weighted logrank tests
- (2019) Dominic Magirr et al. STATISTICS IN MEDICINE
- Methods for Accommodating Nonproportional Hazards in Clinical Trials: Ready for the Primary Analysis?
- (2019) Boris Freidlin et al. JOURNAL OF CLINICAL ONCOLOGY
- Alternative Analysis Methods for Time to Event Endpoints Under Nonproportional Hazards: A Comparative Analysis
- (2019) Ray S. Lin et al. Statistics in Biopharmaceutical Research
- Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial
- (2017) Paolo A Ascierto et al. LANCET ONCOLOGY
- Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma
- (2017) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards
- (2017) Hakim-Moulay Dehbi et al. BMJ-British Medical Journal
- Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards
- (2017) Hakim-Moulay Dehbi et al. BMJ-British Medical Journal
- Survival model construction guided by fit and predictive strength
- (2016) Cécile Chauvel et al. BIOMETRICS
- Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated
- (2016) Patrick Royston et al. BMC Medical Research Methodology
- Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
- (2016) Alexander M.M. Eggermont et al. NEW ENGLAND JOURNAL OF MEDICINE
- Choosing Appropriate Estimands in Clinical Trials
- (2015) Ann-Kristin Leuchs et al. Therapeutic Innovation & Regulatory Science
- Tests for comparing estimated survival functions
- (2014) C. Chauvel et al. BIOMETRIKA
- Analysis of survival data from trials with non-proportional hazards: an empirical comparison of methods
- (2013) Patrick Royston et al. Trials
- The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt
- (2011) Patrick Royston et al. STATISTICS IN MEDICINE
- Maximum of the weighted Kaplan–Meier tests for the two-sample censored data
- (2010) Seung-Hwan Lee JOURNAL OF STATISTICAL COMPUTATION AND SIMULATION
- The Concordance IndexCand the Mann-Whitney Parameter Pr(X>Y) with Randomly Censored Data
- (2009) James A. Koziol et al. BIOMETRICAL JOURNAL
- Improved Logrank-Type Tests for Survival Data Using Adaptive Weights
- (2009) Song Yang et al. BIOMETRICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search